Drugs / PRO-087
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03524157 | Jul 2017 → Feb 2018 | allergic disease, dry eye syndrome | Laboratorios Sophia S.A de C.V. | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03223909 | Oct 2016 → Oct 2018 | dry eye syndrome | Laboratorios Sophia S.A de C.V. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRO-087 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03223909 ↗ |
| Route | Other | “instillation of the ophthalmic solution in the bottom of the conjunctival sac” NCT03223909 ↗ |